Menu
2001 Special Session I

Budget Bill - HB3 (Introduced)

Department of Health

Item 304

Item 304

First Year - FY2001Second Year - FY2002
Communicable and Chronic Disease Prevention and Control (40500)$48,227,284$48,244,396
Cancer Prevention and Control (40501)FY2001 $492,422FY2002 $502,617
Immunization Services (40502)FY2001 $6,859,937FY2002 $6,861,349
Tuberculosis Prevention and Control (40503)FY2001 $1,704,441FY2002 $1,705,050
Venereal Disease Prevention and Control (40504)FY2001 $1,861,027FY2002 $1,861,418
Epidemiological Services (40505)FY2001 $2,457,935FY2002 $2,458,604
Acquired Immune Deficiency Prevention and Treatment Services (40506)FY2001 $21,871,005FY2002 $21,871,884
Technical Assistance and Support for Prevention and Control of Communicable and Chronic Diseases (40507)FY2001 $5,143,589FY2002 $5,145,935
Financial Assistance for Health Prevention and Promotion (40508)FY2001 $7,836,928FY2002 $7,837,539
Fund Sources:  
GeneralFY2001 $12,550,861FY2002 $12,563,166
SpecialFY2001 $598,756FY2002 $598,756
Federal TrustFY2001 $35,077,667FY2002 $35,082,474

Authority: §§ 32.1-11.1 through 32.1-11.2, 32.1-35 through 32.1-73.4, Code of Virginia; and P.L. 91-464, as amended, Federal Code.


A. Out of this appropriation, $1,325,000 the first year and $1,325,000 the second year is provided from the general fund to support the regional AIDS resource and consultation centers and one local early intervention and treatment center.


B. Out of this appropriation, $150,000 the first year and $150,000 the second year is provided from the general fund to support the Arthur Ashe Health Center in Richmond.


C. Appropriations from this Item included for sexual assault centers may be used for adult and children's services provided by the centers and for the sexual assault hotline.


D. Any funds provided in this Item for the Virginia HIV Medications Assistance Program which are unexpended on June 30, 2001, shall not revert to the general fund but shall be reappropriated for the same use in the succeeding year.


E. Out of this appropriation, $50,000 the first year and $50,000 the second year from the general fund shall be provided to the Fan Free Clinic for AIDS related services.


F. The General Assembly finds that access to pharmaceutical therapies is important for treating HIV patients and that patients should have access to a wide range of treatment options as determined under consultation with a physician. The Department shall examine clinical evidence and national guidelines quarterly in order to determine whether additional appropriate forms of treatment and funding for these treatments should be made available through the Virginia HIV Medications Assistance Program. The Department shall report by December 1 of each year to the Joint Subcommittee Studying HIV on its findings and recommendations resulting from an examination of new therapies, including what, if any, additional treatment options and funding should be made available through the Virginia HIV Medications Assistance Program.